I. De-la-réponse-au-traitement...., Importance de l'infiltrat immunitaire initial dans l'évaluation, p.65

M. Agostini, K. P. Janssen, I. J. Kim, E. Angelo, S. Pizzini et al., An integrative approach for the identification of prognostic and predictive biomarkers in rectal cancer, Oncotarget, vol.6, issue.32, p.32561, 2015.
DOI : 10.18632/oncotarget.4935

J. A. Aguirre-ghiso, Models, mechanisms and clinical evidence for cancer dormancy, Nature Reviews Cancer, vol.20, issue.11, 2007.
DOI : 10.1016/j.urolonc.2006.09.018

C. Alix-panabières and K. Pantel, Challenges in circulating tumour cell research, 2014.

C. Allemani, H. K. Weir, H. Carreira, R. Harewood, D. Spika et al., Global surveillance of cancer survival: analysis of individual data for 25 676 887 patients from 279 populationbased registries in 67 countries (CONCORD-2) The Lancet 385, pp.977-1010, 1995.

D. G. Altman, B. Lausen, W. Sauerbrei, and M. Schumacher, Dangers of Using "Optimal" Cutpoints in the Evaluation of Prognostic Factors, JNCI Journal of the National Cancer Institute, vol.86, issue.11, pp.829-835, 1994.
DOI : 10.1093/jnci/86.11.829

M. Anitei, G. Zeitoun, B. Mlecnik, F. Marliot, N. Haicheur et al., Prognostic and Predictive Values of the Immunoscore in Patients with Rectal Cancer, Clinical Cancer Research, vol.20, issue.7, pp.1891-1899, 2014.
DOI : 10.1158/1078-0432.CCR-13-2830

A. L. Appelt, J. Pløen, H. Harling, F. S. Jensen, L. H. Jensen et al., High-dose chemoradiotherapy and watchful waiting for distal rectal cancer: a prospective observational study, The Lancet Oncology, vol.16, issue.8, pp.919-927, 2015.
DOI : 10.1016/S1470-2045(15)00120-5

G. Arbman, E. Nilsson, O. Hallböök, and R. Sjödahl, Local recurrence following total mesorectal excision for rectal cancer, British Journal of Surgery, vol.341, issue.3, pp.375-379, 1996.
DOI : 10.1002/bjs.1800830326

P. Balermpas, Y. Michel, J. Wagenblast, O. Seitz, C. Weiss et al., Tumour-infiltrating lymphocytes predict response to definitive chemoradiotherapy in head and neck cancer, British Journal of Cancer, vol.63, issue.2, pp.501-509, 2014.
DOI : 10.1084/jem.20121416

N. N. Baxter and J. Garcia-aguilar, Organ Preservation for Rectal Cancer, Journal of Clinical Oncology, vol.25, issue.8, pp.1014-1020, 2007.
DOI : 10.1200/JCO.2006.09.7840

S. Benoist, Y. Panis, E. Boleslawski, P. Hautefeuille, and P. Valleur, Functional Outcome After Coloanal Versus Low Colorectal Anastomosis for Rectal Carcinoma, Journal of the American College of Surgeons, vol.185, issue.2, 1997.
DOI : 10.1016/S1072-7515(97)00016-1

G. Bindea, B. Mlecnik, W. Fridman, and J. Galon, The prognostic impact of anti-cancer immune response: a novel classification of cancer patients, Seminars in Immunopathology, vol.27, issue.4, pp.335-340, 2011.
DOI : 10.1200/JCO.2008.21.1540

G. Bindea, B. Mlecnik, M. Tosolini, A. Kirilovsky, M. Waldner et al., Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer, Immunity, vol.39, issue.4, pp.782-795, 2013.
DOI : 10.1016/j.immuni.2013.10.003

G. Bindea, B. Mlecnik, M. Tosolini, A. Kirilovsky, M. Waldner et al., Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer, Immunity, vol.39, issue.4, pp.782-795, 2013.
DOI : 10.1016/j.immuni.2013.10.003

D. S. Bitterman, R. Salgado, L. Moore, H. G. Sanfilippo, N. J. Gu et al., Predictors of Complete Response and Disease Recurrence Following Chemoradiation for Rectal Cancer, Frontiers in Oncology, vol.9, issue.8, 2015.
DOI : 10.1186/s13014-014-0295-2

J. Bosset, G. Calais, L. Mineur, P. Maingon, L. Radosevic-jelic et al., Enhanced Tumorocidal Effect of Chemotherapy With Preoperative Radiotherapy for Rectal Cancer: Preliminary Results???EORTC 22921, Journal of Clinical Oncology, vol.23, issue.24, pp.5620-5627, 2005.
DOI : 10.1200/JCO.2005.02.113

A. Bouvier and G. Launoy, [Epidemiology of colorectal cancer], Rev. Prat, vol.65, pp.767-773, 2015.

H. Brenner, A. M. Bouvier, R. Foschi, M. Hackl, I. K. Larsen et al., Progress in colorectal cancer survival in Europe from the late 1980s to the early 21st century: The EUROCARE study, International Journal of Cancer, vol.15, issue.5 Suppl, 2012.
DOI : 10.1245/s10434-008-0015-y

H. Brenner, M. Kloor, and C. P. Pox, Colorectal cancer, The Lancet, vol.383, issue.9927, pp.1490-502, 2014.
DOI : 10.1016/S0140-6736(13)61649-9

URL : https://hal.archives-ouvertes.fr/hal-01404971

F. M. Burnet, The Concept of Immunological Surveillance, pp.1-27, 1970.
DOI : 10.1159/000386035

M. Burnet, Cancer--A Biological Approach: III. Viruses Associated with Neoplastic Conditions. IV. Practical Applications, BMJ, vol.1, issue.5023, pp.841-847, 1957.
DOI : 10.1136/bmj.1.5023.841

M. Burnet, IMMUNOLOGICAL FACTORS IN THE PROCESS OF CARCINOGENESIS, British Medical Bulletin, vol.20, issue.2, pp.154-158, 1964.
DOI : 10.1093/oxfordjournals.bmb.a070310

A. Cebrián, T. Gómez-del-pulgar, M. J. Fernández-aceñero, A. Borrero-palacios, L. Del-puerto-nevado et al., Decreased PLK1 expression denotes therapy resistance and unfavourable disease-free survival in rectal cancer patients receiving neoadjuvant chemoradiotherapy, Pathology - Research and Practice, vol.212, issue.12, pp.1133-1137, 2016.
DOI : 10.1016/j.prp.2016.09.012

M. Chen, X. Wu, R. Yu, C. Li, L. Wang et al., P53 Status as a Predictive Biomarker for Patients Receiving Neoadjuvant Radiation-Based Treatment: A Meta-Analysis in Rectal Cancer, PLoS ONE, vol.7, issue.9, p.45388, 2012.
DOI : 10.1371/journal.pone.0045388.t003

W. B. Coley, CONTRIBUTION TO THE KNOWLEDGE OF SARCOMA, Annals of Surgery, vol.14, pp.199-220, 1891.
DOI : 10.1097/00000658-189112000-00015

L. Jelic, M. Piérart, C. , and G. , Patients With Curative Resection of cT3-4 Rectal Cancer After Preoperative Radiotherapy or Radiochemotherapy: Does Anybody Benefit From Adjuvant Fluorouracil-Based Chemotherapy? A Trial of the European Organisation for Research and Treatment of Cancer Radiation Oncology Group, J. Clin. Oncol, vol.25, pp.4379-4386, 2007.

N. Y. Crowe, M. J. Smyth, G. , and D. I. , A Critical Role for Natural Killer T Cells in Immunosurveillance of Methylcholanthrene-induced Sarcomas, The Journal of Experimental Medicine, vol.162, issue.1, pp.119-127, 2002.
DOI : 10.1093/intimm/8.11.1759

M. E. Daly, A. M. Monjazeb, K. , and K. , Clinical Trials Integrating Immunotherapy and Radiation for Non???Small-Cell Lung Cancer, Journal of Thoracic Oncology, vol.10, issue.12, pp.1685-1693, 2015.
DOI : 10.1097/JTO.0000000000000686

P. Das, J. M. Skibber, M. A. Rodriguez-bigas, B. W. Feig, G. J. Chang et al., Clinical and Pathologic Predictors of Locoregional Recurrence, Distant Metastasis, and Overall Survival in Patients Treated With Chemoradiation and Mesorectal Excision for Rectal Cancer, American Journal of Clinical Oncology, vol.29, issue.3, pp.219-224, 2006.
DOI : 10.1097/01.coc.0000214930.78200.4a

P. Das, J. M. Skibber, M. A. Rodriguez-bigas, B. W. Feig, G. J. Chang et al., Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer, Cancer, vol.194, issue.9, pp.1750-1755, 2007.
DOI : 10.1016/0360-3016(94)90359-X

D. Dayde, I. Tanaka, R. Jain, M. C. Tai, and A. Taguchi, Predictive and Prognostic Molecular Biomarkers for Response to Neoadjuvant Chemoradiation in Rectal Cancer, International Journal of Molecular Sciences, vol.9, issue.3, 2017.
DOI : 10.1016/j.ctrv.2015.06.007

V. Delmas, Dictionnaire d'anatomie, 2006.

S. Esfahani, R. Kronenwett, and C. Hanusch, Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer, J, 2010.

J. C. Dudley, M. Lin, D. T. Le, and J. R. Eshleman, Microsatellite Instability as a Biomarker for PD-1 Blockade, Clinical Cancer Research, vol.22, issue.4, pp.813-820, 2016.
DOI : 10.1158/1078-0432.CCR-15-1678

G. P. Dunn, A. T. Bruce, H. Ikeda, L. J. Old, and R. D. Schreiber, Cancer immunoediting: from immunosurveillance to tumor escape, Nature Immunology, vol.93, issue.11, pp.991-998, 2002.
DOI : 10.1073/pnas.93.21.11798

G. P. Dunn, C. M. Koebel, and R. D. Schreiber, Interferons, immunity and cancer immunoediting, Nature Reviews Immunology, vol.313, issue.11, pp.836-848, 2006.
DOI : 10.1126/science.1129139

O. Dworak, L. Keilholz, and A. Hoffmann, Pathological features of rectal cancer after preoperative radiochemotherapy, International Journal of Colorectal Disease, vol.12, issue.1, pp.19-23, 1997.
DOI : 10.1007/s003840050072

P. Ehrlich, Über den jetzigen Stand der Karzinomforschung, Beiträge zur experimentellen Pathologie und Chemotherapie, pp.117-164, 1909.

P. Ehrlich, The Collected Papers of Paul Ehrlich of Paul Ehrlich: Immunology and cancer research, 1957.

B. H. Endreseth, P. Romundstad, H. E. Myrvold, T. Bjerkeset, and A. Wibe, Rectal cancer treatment of the elderly, Colorectal Disease, vol.3, issue.6, pp.471-479, 2006.
DOI : 10.2165/00002512-200421070-00003

L. Ferrari and A. Fichera, Neoadjuvant chemoradiation therapy and pathological complete response in rectal cancer, Gastroenterology Report, vol.2, pp.277-288, 2015.
DOI : 10.1007/s11605-015-2814-3

A. Flammiger, F. Bayer, A. Cirugeda-kühnert, H. Huland, P. Tennstedt et al., Intratumoral T but not B lymphocytes are related to clinical outcome in prostate cancer, APMIS, vol.67, issue.11, pp.901-908, 2012.
DOI : 10.5301/JBM.2008.4500

P. Fortina and S. Surrey, Digital mRNA profiling, Nature Biotechnology, vol.24, issue.3, pp.293-294, 2008.
DOI : 10.1038/nbt0308-293

W. H. Fridman, F. Pagès, C. Sautès-fridman, and J. Galon, The immune contexture in human tumours: impact on clinical outcome, Nature Reviews Cancer, vol.29, issue.4, pp.298-306, 2012.
DOI : 10.1200/JCO.2010.30.6308

L. Galluzzi, A. Buqué, O. Kepp, L. Zitvogel, and G. Kroemer, Immunogenic cell death in cancer and infectious disease, Nature Reviews Immunology, vol.16, issue.2, pp.97-111, 2016.
DOI : 10.1038/nrc.2016.16

J. Galon, A. Costes, F. Sanchez-cabo, A. Kirilovsky, B. Mlecnik et al., Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome, Science, vol.313, issue.5795, 1960.
DOI : 10.1126/science.1129139

Y. Gao, W. Yang, M. Pan, E. Scully, M. Girardi et al., ???? T Cells Provide an Early Source of Interferon ?? in Tumor Immunity, The Journal of Experimental Medicine, vol.65, issue.3, pp.433-442, 2003.
DOI : 10.1084/jem.183.4.1681

R. A. Gatti and R. A. Good, Occurrence of malignancy in immunodeficiency diseases: A literature review, Cancer, vol.9, issue.91, pp.89-98, 1971.
DOI : 10.1097/00007611-195701000-00008

T. J. George, G. M. Frampton, J. Sun, K. Gowen, M. Kennedy et al., Tumor mutational burden as a potential biomarker for PD1/PD-L1 therapy in colorectal cancer, J. Clin. Oncol, vol.34, pp.3587-3587, 2016.

J. Gerard, Preoperative Radiotherapy With or Without Concurrent Fluorouracil and Leucovorin in T3-4 Rectal Cancers: Results of FFCD 9203, Journal of Clinical Oncology, vol.24, issue.28, pp.4620-4625, 2006.
DOI : 10.1200/JCO.2006.06.7629

M. Girardi, E. Glusac, R. B. Filler, S. J. Roberts, I. Propperova et al., T Cells to Different Stages of Chemically Induced Skin Cancer, The Journal of Experimental Medicine, vol.156, issue.5, pp.747-755, 2003.
DOI : 10.1073/pnas.96.12.6879

G. G. Grabenbauer, G. Lahmer, L. Distel, and G. Niedobitek, Tumor-Infiltrating Cytotoxic T Cells but not Regulatory T Cells Predict Outcome in Anal Squamous Cell Carcinoma, Clinical Cancer Research, vol.12, issue.11, pp.3355-3360, 2006.
DOI : 10.1158/1078-0432.CCR-05-2434

A. Habr-gama, R. O. Perez, W. Nadalin, J. Sabbaga, U. Ribeiro et al., Operative Versus Nonoperative Treatment for Stage 0 Distal Rectal Cancer Following Chemoradiation Therapy, Transactions of the ... Meeting of the American Surgical Association, vol.CXXII, issue.&NA;, pp.309-316, 2004.
DOI : 10.1097/01.sla.0000141194.27992.32

A. Habr-gama, J. Gama-rodrigues, G. P. Julião, I. Proscurshim, C. Sabbagh et al., Local Recurrence After Complete Clinical Response and Watch and Wait in Rectal Cancer After Neoadjuvant Chemoradiation: Impact of Salvage Therapy on Local Disease Control, International Journal of Radiation Oncology*Biology*Physics, vol.88, issue.4, pp.822-828, 2014.
DOI : 10.1016/j.ijrobp.2013.12.012

J. W. Huh, H. R. Kim, K. , and Y. J. , Clinical Prediction of Pathological Complete Response After Preoperative Chemoradiotherapy for Rectal Cancer, Diseases of the Colon & Rectum, vol.56, issue.6, pp.698-703, 2013.
DOI : 10.1097/DCR.0b013e3182837e5b

J. Bickels, M. D. , Y. Kollender, M. D. Ofer-merinsky, M. D. et al., Medical Archaeology Coley's toxin: Historical Perspective, 2002.

I. Joye, C. M. Deroose, V. Vandecaveye, and K. Haustermans, The role of diffusion-weighted MRI and 18F-FDG PET/CT in the prediction of pathologic complete response after radiochemotherapy for rectal cancer: A systematic review, Radiotherapy and Oncology, vol.113, issue.2, pp.158-165, 2014.
DOI : 10.1016/j.radonc.2014.11.026

E. Kapiteijn, C. A. Marijnen, I. D. Nagtegaal, H. Putter, W. H. Steup et al., Preoperative Radiotherapy Combined with Total Mesorectal Excision for Resectable Rectal Cancer, New England Journal of Medicine, vol.345, issue.9, pp.638-646, 2001.
DOI : 10.1056/NEJMoa010580

O. Kawai, G. Ishii, K. Kubota, Y. Murata, Y. Naito et al., T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer, Cancer, vol.116, issue.6, pp.1387-1395, 2008.
DOI : 10.1136/bmj.311.7010.899

M. E. Keir, M. J. Butte, G. J. Freeman, and A. H. Sharpe, PD-1 and Its Ligands in Tolerance and Immunity, Annual Review of Immunology, vol.26, issue.1, pp.677-704, 2008.
DOI : 10.1146/annurev.immunol.26.021607.090331

C. H. Kim, S. Y. Lee, H. R. Kim, K. , and Y. J. , Prognostic Effect of Pretreatment Serum Carcinoembryonic Antigen Level, Medicine, vol.94, issue.31, 2015.
DOI : 10.1097/MD.0000000000001291

C. J. Kim, T. J. Yeatman, D. Coppola, A. Trotti, B. Williams et al., Local Excision of T2 and T3 Rectal Cancers After Downstaging Chemoradiation, Annals of Surgery, vol.234, issue.3, p.352, 2001.
DOI : 10.1097/00000658-200109000-00009

S. H. Kim, H. J. Chang, D. Y. Kim, J. W. Park, J. Y. Baek et al., What Is the Ideal Tumor Regression Grading System in Rectal Cancer Patients after Preoperative Chemoradiotherapy?, Cancer Research and Treatment, vol.48, issue.3, pp.998-1009, 2016.
DOI : 10.4143/crt.2015.254

G. Klein, Tumor Antigens, Annual Review of Microbiology, vol.20, issue.1, pp.223-252, 1966.
DOI : 10.1146/annurev.mi.20.100166.001255

C. M. Koebel, W. Vermi, J. B. Swann, N. Zerafa, S. J. Rodig et al., Adaptive immunity maintains occult cancer in an equilibrium state, Nature, vol.410, issue.7171, pp.903-907, 2007.
DOI : 10.4049/jimmunol.169.7.3667

L. Kosinski, A. Habr-gama, K. Ludwig, and R. Perez, Shifting concepts in rectal cancer management, CA: A Cancer Journal for Clinicians, vol.50, issue.suppl, pp.173-202, 2012.
DOI : 10.1007/s10350-007-277-7

G. Kroemer, L. Galluzzi, O. Kepp, and L. Zitvogel, Immunogenic Cell Death in Cancer Therapy, Annual Review of Immunology, vol.31, issue.1, pp.51-72, 2013.
DOI : 10.1146/annurev-immunol-032712-100008

E. L. Kuan and S. F. Ziegler, Thymic Stromal Lymphopoietin and Cancer, The Journal of Immunology, vol.193, issue.9, 2014.
DOI : 10.4049/jimmunol.1400864

L. Old and E. A. Boyse, Immunology of Experimental Tumors, Annual Review of Medicine, vol.15, issue.1, 1964.
DOI : 10.1146/annurev.me.15.020164.001123

D. T. Le, J. N. Uram, H. Wang, B. R. Bartlett, H. Kemberling et al., PD-1 Blockade in Tumors with Mismatch-Repair Deficiency, New England Journal of Medicine, vol.372, issue.26, pp.2509-2520, 2015.
DOI : 10.1056/NEJMoa1500596

Y. Lee, H. He, Y. Shiue, S. Lee, L. Lin et al., The prognostic impact of lipid biosynthesis-associated markers, HSD17B2 and HMGCS2, in rectal cancer treated with neoadjuvant concurrent chemoradiotherapy, Tumor Biology, vol.93, issue.Pt 3, pp.7675-7683, 2015.
DOI : 10.1073/pnas.93.12.5925

N. J. Llosa, M. Cruise, A. Tam, E. C. Wicks, E. M. Hechenbleikner et al., The Vigorous Immune Microenvironment of Microsatellite Instable Colon Cancer Is Balanced by Multiple Counter-Inhibitory Checkpoints. Cancer Discov, pp.43-51, 2015.

K. Maeda, Y. Koide, and H. Katsuno, When is local excision appropriate for ???early??? rectal cancer?, Surgery Today, vol.8, issue.suppl, 2000.
DOI : 10.1586/14737140.8.1.111

URL : https://link.springer.com/content/pdf/10.1007%2Fs00595-013-0766-3.pdf

E. F. Mccarthy, The Toxins of William B. Coley and the Treatment of Bone and Soft- Tissue Sarcomas, Iowa Orthop. J, vol.26, pp.154-158, 2006.

L. Monney, C. A. Sabatos, J. L. Gaglia, A. Ryu, H. Waldner et al., Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease, Nature, vol.256, issue.6871, pp.536-541, 2002.
DOI : 10.1038/256495a0

P. B. Olkhanud, Y. Rochman, M. Bodogai, E. Malchinkhuu, K. Wejksza et al., Thymic Stromal Lymphopoietin Is a Key Mediator of Breast Cancer Progression, The Journal of Immunology, vol.186, issue.10, pp.5656-5662, 1950.
DOI : 10.4049/jimmunol.1100463

F. Pagès, A. Berger, M. Camus, F. Sanchez-cabo, A. Costes et al., Effector Memory T Cells, Early Metastasis, and Survival in Colorectal Cancer, New England Journal of Medicine, vol.353, issue.25, pp.2654-2666, 2005.
DOI : 10.1056/NEJMoa051424

F. Pages, A. Kirilovsky, B. Mlecnik, M. Asslaber, M. Tosolini et al., In Situ Cytotoxic and Memory T Cells Predict Outcome in Patients With Early-Stage Colorectal Cancer, Journal of Clinical Oncology, vol.27, issue.35, pp.5944-5951, 2009.
DOI : 10.1200/JCO.2008.19.6147

J. Park, M. Jang, Y. E. Tarhan, T. Katagiri, M. Sasa et al., Clonal expansion of antitumor T cells in breast cancer correlates with response to neoadjuvant chemotherapy, International Journal of Oncology, vol.49, issue.2, pp.471-478, 2016.
DOI : 10.3892/ijo.2016.3540

S. S. Park, H. Dong, X. Liu, S. M. Harrington, C. J. Krco et al., PD-1 Restrains Radiotherapy-Induced Abscopal Effect, Cancer Immunology Research, vol.3, issue.6, pp.610-619, 2015.
DOI : 10.1158/2326-6066.CIR-14-0138

U. B. Patel, F. Taylor, L. Blomqvist, C. George, H. Evans et al., Magnetic Resonance Imaging???Detected Tumor Response for Locally Advanced Rectal Cancer Predicts Survival Outcomes: MERCURY Experience, Journal of Clinical Oncology, vol.29, issue.28, pp.3753-3760, 2011.
DOI : 10.1200/JCO.2011.34.9068

I. Penn, Posttransplant malignancies, Transplantation Proceedings, vol.31, issue.1-2, pp.1260-1262, 1999.
DOI : 10.1016/S0041-1345(98)01987-3

I. Penn, C. G. Halgrimson, and T. E. Starzl, De Novo Malignant Tumors in Organ Transplant Recipients, Transplant. Proc, vol.3, pp.773-778, 1971.

C. P. Probst, A. Z. Becerra, C. T. Aquina, M. A. Tejani, B. J. Hensley et al., Watch and Wait????Elevated Pretreatment CEA Is Associated with Decreased Pathological Complete Response in Rectal Cancer, Journal of Gastrointestinal Surgery, vol.31, issue.1, pp.43-52, 2016.
DOI : 10.1016/S0360-3016(02)02764-5

H. Qiu, B. Wu, Y. Xiao, L. , and G. , Combination of differentiation and T stage can predict unresponsiveness to neoadjuvant therapy for rectal cancer, Colorectal Disease, vol.12, issue.12, pp.1353-1360, 2011.
DOI : 10.1111/j.1463-1318.2009.02054.x

G. Redelman-sidi, M. S. Glickman, and B. H. Bochner, The mechanism of action of BCG therapy for bladder cancer???a current perspective, Nature Reviews Urology, vol.59, issue.3, pp.153-162, 2014.
DOI : 10.1159/000283049

K. Reynders, T. Illidge, S. Siva, J. Y. Chang, D. Ruysscher et al., The abscopal effect of local radiotherapy: using immunotherapy to make a rare event clinically relevant, Cancer Treatment Reviews, vol.41, issue.6, pp.503-510, 2015.
DOI : 10.1016/j.ctrv.2015.03.011

A. Senéjoux, Séquelles fonctionnelles digestives après chirurgie du cancer du rectum, 2011.

V. Shankaran, H. Ikeda, A. T. Bruce, J. M. White, P. E. Swanson et al., IFN? and lymphocytes prevent primary tumour development and shape tumour immunogenicity, Nature, vol.410, issue.6832, pp.1107-1111, 2001.
DOI : 10.1038/35074122

S. Sierro, P. Romero, and D. E. Speiser, The CD4-like molecule LAG-3, biology and therapeutic applications, Expert Opinion on Therapeutic Targets, vol.11, issue.1, pp.91-101, 2011.
DOI : 10.1016/S1470-2045(09)70334-1

K. D. Smith, D. Tan, P. Das, G. J. Chang, K. Kattepogu et al., Clinical Significance of Acellular Mucin in Rectal Adenocarcinoma Patients With a Pathologic Complete Response to Preoperative Chemoradiation, Annals of Surgery, vol.251, issue.2, pp.261-264, 2010.
DOI : 10.1097/SLA.0b013e3181bdfc27

M. J. Smyth, N. Y. Crowe, G. , and D. I. , NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma, International Immunology, vol.13, issue.4, pp.459-463, 2001.
DOI : 10.1084/jem.192.5.741

T. Stornes, A. Wibe, and B. H. Endreseth, Complications and risk prediction in treatment of elderly patients with rectal cancer, International Journal of Colorectal Disease, vol.8, issue.17, pp.87-93, 2016.
DOI : 10.1016/S1470-2045(07)70045-1

W. Sun, G. Li, J. Wan, J. Zhu, W. Shen et al., Circulating tumor cells: A promising marker of predicting tumor response in rectal cancer patients receiving neoadjuvant chemo-radiation therapy, Oncotarget, vol.7, issue.43, pp.69507-69517, 2016.
DOI : 10.18632/oncotarget.10875

N. Takahashi, M. Sugaya, H. Suga, T. Oka, M. Kawaguchi et al., Thymic Stromal Chemokine TSLP Acts through Th2 Cytokine Production to Induce Cutaneous T-cell Lymphoma, Cancer Research, vol.76, issue.21, pp.6241-6252, 2016.
DOI : 10.1158/0008-5472.CAN-16-0992

F. Teng, D. Mu, X. Meng, L. Kong, H. Zhu et al., Tumor infiltrating lymphocytes (TILs) before and after neoadjuvant chemoradiotherapy and its clinical utility for rectal cancer, Am. J. Cancer Res, vol.5, pp.2064-2074, 2015.

S. Thies and R. Langer, Tumor Regression Grading of Gastrointestinal Carcinomas after Neoadjuvant Treatment. Front, Oncol, vol.3, 2013.

L. Thomas, Cellular and Humoral Aspects of Hypersensitivity, 1959.

D. Tougeron, E. Fauquembergue, A. Rouquette, L. Pessot, F. Sesboüé et al., Tumor-infiltrating lymphocytes in colorectal cancers with microsatellite instability are correlated with the number and spectrum of frameshift mutations, Modern Pathology, vol.30, issue.9, pp.1186-1195, 2009.
DOI : 10.1371/journal.pone.0002583

. Twyman-saint, C. Victor, A. J. Rech, A. Maity, R. Rengan et al., Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer, Nature, vol.67, issue.7547, pp.373-377, 2015.
DOI : 10.1007/s00285-012-0589-7

J. Weber, C. Horak, F. S. Hodi, H. Chang, D. Woods et al., Baseline tumor T cell receptor (TcR) sequencing analysis and neo antigen load is associated with benefit in melanoma patients receiving sequential nivolumab and ipilimumab, Annals of Oncology, vol.27, issue.suppl_6, 2016.
DOI : 10.1093/annonc/mdw378.01

B. Wiemann and C. O. Starnes, Coley's toxins, tumor necrosis factor and cancer research: A historical perspective, Pharmacology & Therapeutics, vol.64, issue.3, pp.529-564, 1994.
DOI : 10.1016/0163-7258(94)90023-X

K. Yasuda, T. Nirei, E. Sunami, H. Nagawa, and J. Kitayama, Density of CD4(+) and CD8(+) T lymphocytes in biopsy samples can be a predictor of pathological response to chemoradiotherapy (CRT) for rectal cancer, Radiation Oncology, vol.6, issue.1, p.49, 2011.
DOI : 10.1038/nm1622

Y. N. You, Local Excision: Is It an Adequate Substitute for Radical Resection in T1/T2 Patients?, Seminars in Radiation Oncology, vol.21, issue.3, pp.178-184, 2011.
DOI : 10.1016/j.semradonc.2011.02.003

A. Zaanan, J. M. Park, D. Tougeron, S. Huang, T. Wu et al., Association of beclin 1 expression with response to neoadjuvant chemoradiation therapy in patients with locally advanced rectal carcinoma, International Journal of Cancer, vol.65, issue.6, pp.1498-1502, 2015.
DOI : 10.1136/jclinpath-2012-200958

W. Zeng, J. Liang, Z. Wang, X. Zhang, J. Hu et al., Clinical parameters predicting pathologic complete response following neoadjuvant chemoradiotherapy for rectal cancer, Chinese Journal of Cancer, vol.30, issue.14, p.41, 2015.
DOI : 10.1200/JCO.2011.39.6036

L. Zitvogel, L. Apetoh, F. Ghiringhelli, and G. Kroemer, Immunological aspects of cancer chemotherapy, Nature Reviews Immunology, vol.313, issue.1, pp.59-73, 2008.
DOI : 10.4049/jimmunol.172.4.2039

L. Zitvogel, L. Galluzzi, M. J. Smyth, and G. Kroemer, Mechanism of Action of Conventional and Targeted Anticancer Therapies: Reinstating Immunosurveillance, Immunity, vol.39, issue.1, pp.74-88, 2013.
DOI : 10.1016/j.immuni.2013.06.014